{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Flenacapavir-for-hiv-YKbaS9wT","width":444,"version":"1.0","type":"rich","title":"Long-Acting ART: Lenacapavir","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/ec27f4da-698a-4896-98b8-8c9690bd44ff/cmoh-dm-5074-pod1-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/219e194e-152b-4b3e-a0b9-67830484768a\" height=\"200\" width=\"100%\" title=\"Long-Acting ART: Lenacapavir\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Darcy Wooten, MD, discuss the long-acting HIV treatment agent lenacapavir for treatment-experienced PWH, including efficacy data, initiation strategies, virologic failure data, and safety information."}